Search filters

Filters
Clear All

Phase

  • 3
  • 1
  • 12
  • 48
  • 64
  • 3
  • 2
  • 5
  • 57
  • 63
  • 1

Found 64 abramson-cancer-center trials

A listing of abramson-cancer-center medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Sort by:
18 years or above
All genders
Phase 2
Interventional
This study investigates the effects of combining an investigational medication with another treatment for patients with metastatic colorectal cancer that primarily affects the liver. In this study, researchers are looking at how the combination treatment works and its safety for patients.Participants in the study will receive the investigational medication along …
UPCC 11125: The MILES Study: A Mixed-Methods Metabolomics Investigation of Lifestyle and Energy Balance During Breast Cancer Survivorship
18 years or above
Female
Interventional
This study investigates breast cancer. It focuses on understanding lifestyle and energy balance in women during early treatment stages.The study evaluates dietary quality and physical activity over time. It also looks at how these factors can support healthy behaviors in patients.Who can participate: Adult women aged 18 years or older …
18 years or above
Accepts healthy volunteer
All genders
This study investigates the use of investigational medications, specifically pembrolizumab alone or in combination with lenvatinib, for treating high risk renal cell carcinoma. The purpose of this study is to see how these medications affect the immune system's response to the cancer when given before and after surgery to remove …
60 years or above
All genders
Interventional
This study investigates the impact of a supervised exercise program on outcomes for older adults undergoing allogeneic hematopoietic cell transplantation (HCT). The purpose of this study is to see if such an exercise program can be successfully implemented.Participants will be divided into two study arms: Cohort A (Prehab) and Cohort …
18 years or above
All genders
Phase 2
Interventional
This study investigates the use of ultrahypofractionated whole pelvis proton therapy with a brachytherapy boost for patients with high risk or unfavorable intermediate risk prostate cancer. This study aims to understand the effectiveness of this treatment method for those with a higher risk of cancer spreading to lymph nodes.Participants in …
18 years or above
All genders
Interventional
This study investigates the safety and tolerability of β-hydroxybutyrate (BHB) supplementation in patients receiving standard-of-care anti-CD19 CAR T-cells for the treatment of lymphoma. The purpose of this study is to determine if BHB supplementation, administered orally, affects the gut microbiome and peripheral blood mononuclear cells (PBMCs) in these patients.Participants will …
18 years or above
All genders
Interventional
This study investigates the effectiveness of a self-management program for head and neck cancer survivors who experience lymphedema and fibrosis. The purpose of this study is to evaluate how well the self-management program can help manage these conditions and improve the quality of life for participants.Participants will be assigned to …
50 years - 80 years
All genders
Interventional
This study investigates the use of telehealth strategies to improve shared decision-making (SDM) visits for lung cancer screening (LCS). Lung cancer screening often involves low-dose computed tomography (LDCT), which can reduce lung cancer mortality but also carries risks. Patients are recommended to complete an SDM visit to discuss these risks …
18 years - 45 years
Accepts healthy volunteer
All genders
The purpose of this study is to investigate communication strategies to increase the uptake of the HPV vaccine among adults. The study focuses on finding effective ways to communicate the importance of the HPV vaccine to adults, as the vaccination rates are currently low in this group.Participants in this study …
UPCC 04219 Phase 2 Study of Capecitabine-Temozolomide(CapTem) with yttrium-90 Radioembolization in the Treatment of Patients with Unresectable Metastatic Grade 2/3 Neuroendocrine Tumors
18 years or above
All genders
Phase 2
Interventional
This study investigates the treatment of patients with unresectable metastatic neuroendocrine tumors (NETs) that are primarily located in the liver. The purpose of this study is to evaluate the effectiveness and safety of a combination treatment using Capecitabine-Temozolomide (CapTem) and yttrium-90 (Y90) radioembolization.Participants in the study will receive CapTem, which …